Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
"DNA synthesis in epidermal cells" refers to the **biological process by which new DNA is replicated within the nuclei of dividing keratinocytes**, primarily located in the basal layer of the epidermis. This process is essential for normal skin growth, maintenance, and repair following injury. It is tightly regulated by both intrinsic cellular mechanisms and extrinsic factors such as barrier disruption; for example, damage to the skin's permeability barrier leads to increased rates of epidermal DNA synthesis as part of regenerative hyperplasia[1]. Measurement techniques include autoradiography and liquid scintillation counting using labeled nucleotide precursors like 3H-thymidine[2]. While critical for tissue homeostasis, abnormal regulation can contribute to diseases such as cancer or chronic inflammatory conditions.
Inhibition or stimulation of enzymes involved in the cell cycle/DNA replication (e.g., DNA polymerase inhibitors) Modulation of signaling pathways controlling entry into S-phase
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on DNA synthesis in epidermal cells (null).